Lilly sees profit topping Wall Street (Reuters)

RSS News User · 10th December 2005, 02:25 AM

<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20051209/bs_nm/lilly_outlook_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051209/2005_12_09t081246_450x299_us_lilly_outlook.jpg?x=1 30&y=86&sig=8w_Z0LBFn57I_mzluTyJ.A--" align="left" height="86" width="130" alt="The Eli Lilly drug Cymbalta is seen in an undated photo. Eli Lilly and Co. on Friday said it expects its 2006 earnings to be above Wall Street expectations, fueled by strong sales growth of newer drugs and a lower than expected tax rate. (PRNewsFoto/Reuters)" border="0" /></a>Reuters - Eli Lilly and Co. on Friday
said 2006 earnings should top Wall Street forecasts on growing
demand for its new drugs and stabilizing U.S. sales of its
Zyprexa schizophrenia treatment, sending shares higher in
pre-market trade.</p><br clear=all>

View the entire article: Lilly sees profit topping Wall Street (Reuters)